Anumana
Anumana, Inc. is a cardiac AI health-technology company founded as a joint venture between Mayo Clinic and nference, commercializing ECG-AI algorithms that read standard 10-second, 12-lead electrocardiograms to surface disease signals that are not visible to the human eye. Its portfolio includes the FDA-cleared ECG-AI LEF algorithm for detecting low ejection fraction in patients at risk of heart failure (trained on roughly 2.9 million ECG-echo pairs across 676,000+ patients), the first and only FDA-cleared ECG-AI algorithm for cardiac amyloidosis, and an FDA-cleared algorithm for early detection of pulmonary hypertension, plus a pipeline that includes hyperkalemia. Anumana is delivered as a regulated medical device that runs inside the customer's own ECG management system and EHR environment, ingesting digital waveform files and returning results into clinical workflow rather than being consumed as a public developer API.
Anumana is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Artificial Intelligence, Machine-Learning, and Medical Devices.
Anumana’s developer surface includes documentation, support, engineering blog, FAQ, and 19 more developer resources.
Kin Score
Security Posture 3
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 2
Portal, sign-up, and the first successful call
Documentation 1
Reference material describing how the API behaves
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Access & Security 5
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API
Other 4
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.